153 related articles for article (PubMed ID: 2847642)
1. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.
Karlsson A; Harmenberg J
Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
[TBL] [Abstract][Full Text] [Related]
3. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
Coen DM; Goldstein DJ; Weller SK
Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
[TBL] [Abstract][Full Text] [Related]
5. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
Safrin S; Schacker T; Delehanty J; Hill E; Corey L
Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815
[TBL] [Abstract][Full Text] [Related]
8. Role of viral ribonucleotide reductase in the increase of dTTP pool size in herpes simplex virus-infected Vero cells.
Daikoku T; Yamamoto N; Maeno K; Nishiyama Y
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1441-4. PubMed ID: 1646284
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
Prichard MN; Shipman C
Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
Spector T; Stonehuerner JG; Biron KK; Averett DR
Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected HeLa cells.
Nakayama K; Ruth JL; Cheng YC
J Virol; 1982 Jul; 43(1):325-7. PubMed ID: 6287006
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of thymidylate synthase and dihydrofolate reductase potentiate the antiviral effect of acyclovir.
Prichard MN; Prichard LE; Shipman C
Antiviral Res; 1993 Mar; 20(3):249-59. PubMed ID: 8385896
[TBL] [Abstract][Full Text] [Related]
13. The sources of thymidine nucleotides for virus DNA synthesis in herpes simplex virus type 2-infected cells.
Nutter LM; Grill SP; Cheng YC
J Biol Chem; 1985 Oct; 260(24):13272-5. PubMed ID: 2997161
[TBL] [Abstract][Full Text] [Related]
14. Deoxyribonucleotide metabolism in Herpes simplex virus infected HeLa cells.
Cheng YC; Goz B; Prusoff WH
Biochim Biophys Acta; 1975 May; 390(3):253-63. PubMed ID: 164949
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y
Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
Averett DR; Furman PA; Spector T
J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
18. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
Lobe DC; Spector T; Ellis MN
Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
[TBL] [Abstract][Full Text] [Related]
19. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
Furman PA; Lambe CU; Nelson DJ
Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
[TBL] [Abstract][Full Text] [Related]
20. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
Lawetz C; Liuzzi M
Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
